BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Van der Merwe S, Chokshi S, Bernsmeier C, Albillos A. The multifactorial mechanisms of bacterial infection in decompensated cirrhosis. J Hepatol 2021;75 Suppl 1:S82-S100. [PMID: 34039494 DOI: 10.1016/j.jhep.2020.11.029] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Lotersztajn S, Riva A, Wang S, Dooley S, Chokshi S, Gao B. Inflammation in alcohol-associated liver disease progression. Z Gastroenterol 2022;60:58-66. [PMID: 35042254 DOI: 10.1055/a-1714-9246] [Reference Citation Analysis]
2 Wu J, Bortolanza M, Zhai G, Shang A, Ling Z, Jiang B, Shen X, Yao Y, Yu J, Li L, Cao H. Gut microbiota dysbiosis associated with plasma levels of Interferon-γ and viral load in patients with acute hepatitis E infection. J Med Virol 2022;94:692-702. [PMID: 34549810 DOI: 10.1002/jmv.27356] [Reference Citation Analysis]
3 Xue X, Wu J, Ding M, Gao F, Zhou F, Xu B, Lu M, Li J, Li X. Si-Wu-Tang ameliorates fibrotic liver injury via modulating intestinal microbiota and bile acid homeostasis. Chin Med 2021;16:112. [PMID: 34736501 DOI: 10.1186/s13020-021-00524-0] [Reference Citation Analysis]
4 Kremer WM, Gairing SJ, Kaps L, Ismail E, Kalampoka V, Hilscher M, Michel M, Siegel E, Schattenberg JM, Galle PR, Sprinzl MF, Wörns MA, Nagel M, Labenz C. Characteristics of bacterial infections and prevalence of multidrug-resistant bacteria in hospitalized patients with liver cirrhosis in Germany. Ann Hepatol 2022;:100719. [PMID: 35460883 DOI: 10.1016/j.aohep.2022.100719] [Reference Citation Analysis]
5 Liu Y, Chen M. Clostridioides difficile Infection in Liver Cirrhosis: A Concise Review. Can J Gastroenterol Hepatol 2022;2022:4209442. [PMID: 35711246 DOI: 10.1155/2022/4209442] [Reference Citation Analysis]
6 Jalan R, Szabo G. New concepts and perspectives in decompensated cirrhosis. J Hepatol 2021;75 Suppl 1:S1-2. [PMID: 34039481 DOI: 10.1016/j.jhep.2020.12.008] [Reference Citation Analysis]
7 Nagel M, Labenz C, Dobbermann H, Czauderna C, Wallscheid NC, Schattenberg JM, Wörns MA, Galle PR, Marquardt JU. Suppressed serological vitamin A in patients with liver cirrhosis is associated with impaired liver function and clinical detoriation. Eur J Gastroenterol Hepatol 2022. [PMID: 35895982 DOI: 10.1097/MEG.0000000000002418] [Reference Citation Analysis]
8 Lamatsch S, Sittner R, Tacke F, Engelmann C. Novel drug discovery strategies for the treatment of decompensated cirrhosis. Expert Opin Drug Discov 2021;:1-10. [PMID: 34971342 DOI: 10.1080/17460441.2022.2020755] [Reference Citation Analysis]